The academic journey within the classroom continued with further building on courses in finance, global businesses, and general management. Some of my favorites were – Entrepreneurial Finance, Global Economic Challenges, and Business Law. E Finance provided further insights into the financial structures pertinent in VC and PE industry, dynamics of interplay various involved parties, particularly LPs and GPs, and good line-up of speakers from lawyers, fund managers, to entrepreneurs. Highly recommended for anyone with aspirations towards entrepreneurship in a private or corporate setting. Global economic challenges, taught by rock-star faculty, Kristin Forbes, exceeded the expectations! Beyond discussions on previous significant economic crisis, policy issues and implications; the real-time discussions of the current economic crisis and actions of various countries, made 8:30 am classes to be something to look forward to. To top it off, Kristin’s personal anecdotes of inner working of the White House, including one special session to it, was humorous, enlightening, and very educational! (Kristin was one of the economic advisors to the President George HW Bush). The MIT Sloan experience in incomplete without this course! The Business Law course by John Akula, I believe is a must for any business leader. Starting off with basic premise of the US law, the course rapidly went into details of bankruptcy law and general corporate law. A fantastic overview! Additionally, a fantastic line-up of more than a dozen lawyers, explained how these are practiced in real life; presenting both the government and company’s viewpoints (especially when GM and Chrysler about to file for bankruptcy, incompletion of several high profile M&As).
Outside classroom, I continued my field study with Staley Capital, wherein I was involved with developing investment thesis focusing on the healthcare sector, in particular focusing Custom Research and Manufacturing Organizations (CROs & CMOs). After my initial foray into healthcare, during my first semester, this was a fantastic opportunity to gain more insights into this and put learning the classroom into practice. With new Obama administration, and uphill challenges in healthcare – thin product pipeline, ageing population, and slim hit rate, coupled with huge cost to develop next blockbuster drug; this sector presents unique set of challenges and opportunities. Our focus, was therefore to analyze CRO and CMO landscape globally, evaluating companies that might benefit significantly from these trends. The work ultimately led to healthcare being one of the key sectors for the firm in 2009 and beyond.